Viome Life Sciences last raised $25.4M in its Early Stage VC (Aug 2024).
- ·The complete investor list: 20 names
- ·Watch Viome Life Sciences: the Monday email on marks, rounds and moves
Viome Life Sciences funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Aug 2024 | Early Stage VC | $25.4M | ▮ | ▮ |
| Sep 2022 | Later Stage VC | $67.0M | ▮ | ▮ |
Membership and data by Private Market View
Viome Life Sciences valuation
Viome Life Sciences's last known valuation is $415 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How much has Viome Life Sciences raised?
Viome Life Sciences has raised $235 million in total; 2 of its rounds are on record. The largest on record was a $67 million later-stage round in Sep 2022; the most recent was a $25.4 million early-stage round in Aug 2024.
Viome Life Sciences has filed 2 Form Ds with the SEC since 2022, most recently in Aug 2024 ($25.4 million sold to 44 investors).
How Viome Life Sciences's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Viome Life Sciences, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Viome Life Sciences
- What is Viome Life Sciences worth?
- Viome Life Sciences's last known valuation is $415.4M.
- How much has Viome Life Sciences raised?
- Viome Life Sciences has raised $235.4M in total funding across 2 recorded rounds.
- When did Viome Life Sciences last raise?
- Viome Life Sciences last raised in Aug 2024 (Early Stage VC), raising $25.4M.